Long-acting gonadotropin-releasing hormone agonist trigger in fertility preservation cycles before chemotherapy

BACKGROUND: Oocytes/embryo cryopreservation and ovarian function suppression with gonadotropin-releasing hormone (GnRH) agonists (GnRHas) are two established strategies for preserving fertility in patients with cancer, frequently both being offered to the same woman. As the first injection of GnRHa...

Descripción completa

Detalles Bibliográficos
Autores principales: Massarotti, C., Stigliani, S., Gazzo, I., Lambertini, M., Anserini, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485390/
https://www.ncbi.nlm.nih.gov/pubmed/37421801
http://dx.doi.org/10.1016/j.esmoop.2023.101597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485390/
https://www.ncbi.nlm.nih.gov/pubmed/37421801
http://dx.doi.org/10.1016/j.esmoop.2023.101597

Ejemplares similares